[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Leiter, A., Veluswamy, R.R. and Wisnivesky, J.P. (2023) The Global Burden of Lung Cancer: Current Status and Future Trends. Nature Reviews Clinical Oncology, 20, 624-639. https://doi.org/10.1038/s41571-023-00798-3
|
[3]
|
Cao, M. and Chen, W. (2019) Epidemiology of Lung Cancer in China. Thoracic Cancer, 10, 3-7.
https://doi.org/10.1111/1759-7714.12916
|
[4]
|
Detterbeck, F.C., Boffa, D.J., Kim, A.W., et al. (2017) The Eighth Edition Lung Cancer Stage Classification. Chest, 151, 193-203. https://doi.org/10.1016/j.chest.2016.10.010
|
[5]
|
张晓菊, 白莉, 金发光, 等. 肺结节诊治中国专家共识(2018年版) [J]. 中华结核和呼吸杂志, 2018, 41(10): 763-771.
|
[6]
|
孙影. 69957例健康体检人群肺结节患病率和危险因素分析[D]: [硕士学位论文]. 合肥: 安徽医科大学内科学, 2022.
|
[7]
|
史景云, 孙奋勇, 刘海鹏, 等. 肺部多发磨玻璃结节中西医结合防治一体化专家共识[J]. 肿瘤, 2022, 42(7): 451-465.
|
[8]
|
Sender, R., Fuchs, S. and Milo, R. (2016) Revised Estimates for the Number of Hu-man and Bacteria Cells in the Body. PLOS Biology, 14, e1002533. https://doi.org/10.1371/journal.pbio.1002533
|
[9]
|
Wang, L., Cai, Y., Garssen, J., et al. (2023) The Bidirectional Gut-Lung Axis in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 207, 1145-1160.
https://doi.org/10.1164/rccm.202206-1066TR
|
[10]
|
Narayana, J.K., Aliberti, S., Mac, Aogáin, M., et al. (2023) Mi-crobial Dysregulation of the Gut-Lung Axis in Bronchiectasis. American Journal of Respiratory and Critical Care Medi-cine, 207, 908-920.
https://doi.org/10.1164/rccm.202205-0893OC
|
[11]
|
Hou, K., Wu, Z., Chen, X., et al. (2022) Microbiota in Health and Diseases. Signal Transduction and Targeted Therapy, 7, Article No. 135. https://doi.org/10.1038/s41392-022-00974-4
|
[12]
|
Nagasaka, M., Sexton, R., Alhasan, R., et al. (2020) Gut Micro-biome and Response to Checkpoint Inhibitors in Non-Small Cell Lung Cancer—A Review. Critical Reviews in Oncolo-gy/Hematology, 145, Article ID: 102841.
https://doi.org/10.1016/j.critrevonc.2019.102841
|
[13]
|
Zitvogel, L., Daillère, R., Roberti, M.P., et al. (2017) Anti-cancer Effects of the Microbiome and Its Products. Nature Reviews Microbiology, 15, 465-478. https://doi.org/10.1038/nrmicro.2017.44
|
[14]
|
Bingula, R., Filaire, M., Radosevic-Robin, N., et al. (2018) Charac-terisation of Gut, Lung, and Upper Airways Microbiota in Patients with Non-Small Cell Lung Carcinoma. Medicine, 97, e13676.
https://doi.org/10.1097/MD.0000000000013676
|
[15]
|
Zhang, W., Zhao, S., Luo, J., et al. (2018) Alterations of Fe-cal Bacterial Communities in Patients with Lung Cancer. American Journal of Translational Research, 10, 3171-3185.
|
[16]
|
Pope, J.L., Tomkovich, S., Yang, Y., et al. (2017) Microbiota as a Mediator of Cancer Progression and Therapy. Translational Research, 179, 139-154. https://doi.org/10.1016/j.trsl.2016.07.021
|
[17]
|
韩群啸, 鲍国林, 刘义庆. 肺癌早期诊断研究进展[J]. 中国医药, 2023, 18(5): 761-764.
|
[18]
|
Louis, P. and Flint, H.J. (2016) For-mation of Propionate and Butyrate by the Human Colonic Microbiota. Environmental Microbiology, 19, 29-41. https://doi.org/10.1111/1462-2920.13589
|
[19]
|
倪园园, 王至婉, 赵正阳. 基于辨病辨体探讨肺结节的中医治疗[J]. 辽宁中医杂志, 2023, 66(7): 1-8.
|
[20]
|
李玥, 张馨月, 何姝霖, 等. 肺结节临床症状及中医证候分布特征[J]. 中国中药杂志, 2023, 48(17): 4782-4788.
|
[21]
|
赵婷婷. 271例肺部结节患者中医证型分布及与体质的相关性分析[D]: [硕士学位论文]. 北京: 北京中医药大学, 2021.
|
[22]
|
姜朋媛. 肺结节的中医证素分布特征研究[D]: [硕士学位论文]. 北京: 北京中医药大学, 2021.
|
[23]
|
向科旭, 汪真辉, 瞿颖, 等. 100例亚厘米肺结节手术患者中医证型与病理分析[J]. 广州中医药大学学报, 2022, 39(8): 1732-1738.
|
[24]
|
张兴涵, 张怀锐, 念家云, 等. 肺结节中西医结合全程管理专家共识[J]. 中国实验方剂学杂志, 2023, 30(1): 1-14.
|
[25]
|
李要远, 郑红刚, 程孟祺. 基于扶正调气法治疗肺结节的运用初探[J]. 中医药学报, 2022, 50(4): 1-4.
|
[26]
|
亓润智, 赵雨薇, 栾美琪, 等. 花宝金调气解毒治疗肺结节思想探析[J]. 世界中医药, 2022, 17(11): 1535-1539.
|
[27]
|
田昊. 基于数据挖掘探讨龚红卫教授治疗肺结节的用药规律[D]: [硕士学位论文]. 武汉: 湖北中医药大学, 2022.
|
[28]
|
刘颖. 运用徐力教授肺结方干预肺结节临床研究[D]: [硕士学位论文]. 南京: 南京中医药大学, 2022.
|